Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Glucose-lowering Drugs
100%
Glycemic Control
100%
Type 2 Diabetic Patients
100%
Potential Risk
100%
Severe Hypoglycemia
100%
Hypoglycemia Risk
100%
Network Meta-analysis
100%
Drug Treatment Regimen
100%
Insulin
85%
Glinides
71%
Non-insulin
57%
Sulfonylurea
42%
Surface under the Cumulative Ranking Curve
42%
Thiazolidinediones
28%
High Efficacy
28%
Glucagon-like peptide-1 (GLP-1)
28%
Hemoglobin A1c (HbA1c)
14%
A1 Receptor
14%
Cluster Analysis
14%
Receptor Agonist
14%
Embase
14%
MEDLINE
14%
Glucagon-like
14%
Insulin Therapy
14%
High Safety
14%
Secretagogue
14%
Good Glycemic Control
14%
Premixed Insulin
14%
Treatment Hierarchy
14%
Medicine and Dentistry
Drug Therapy
100%
Maturity Onset Diabetes of the Young
100%
Patient with Type 2 Diabetes
100%
Glycemic Control
100%
Hypoglycemia
100%
Network Meta-Analysis
100%
Sulfonylurea
37%
Thiazolidinedione
25%
Hemoglobin A1c
12%
Cluster Analysis
12%
Clinician
12%
Insulin Treatment
12%
Glucagon-Like Peptide-1 Agonist
12%
Secretagogue
12%
Nursing and Health Professions
Drug Therapy
100%
Patient with Type 2 Diabetes
100%
Hypoglycemia
100%
Non Insulin Dependent Diabetes Mellitus
100%
Network Meta-Analysis
100%
Sulfonylurea
37%
Thiazolidinedione
25%
Hemoglobin A1c
12%
Insulin Treatment
12%
Glucagon Like Peptide 1 Receptor Agonist
12%
Cluster Analysis
12%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
Hypoglycemia
100%
Non Insulin Dependent Diabetes Mellitus
100%
Insulin Analog
62%
Sulfonylurea
37%
Thiazolidinedione
25%
Hemoglobin A1c
12%
Glucagon Like Peptide 1 Receptor Agonist
12%
Agricultural and Biological Sciences
Meta-Analysis
100%
Glycemic Control
100%
Insulin Analog
71%
Sulfonylurea
42%
Thiazolidinedione
28%
Agonist
14%
Cluster Analysis
14%
Glucagon-Like Peptide 1 Receptor
14%
Biochemistry, Genetics and Molecular Biology
Glycemic Control
100%
Insulin Analog
71%
Sulfonylurea
42%
Thiazolidinedione
28%
Glycosylated Hemoglobin
14%
Receptor Agonists
14%
Cluster Analysis
14%
Glucagon-Like Peptide 1 Receptor
14%